To this extent, glatiramer acetate, which is used in MS, has been found to bind abzymes (antibodies with enzyme activity) that can be seen in some patients with ME/CFS and can damage the myelin basic protein that covers nerves in the human body [179]. The gene discussed is MBP; the disease is myeloid sarcoma.